CTRI/2021/04/032865尚未招募未知
COVID-19 with Hematological Cancers Registry of India - CHCRI registry
Tata Memorial Hospital Mumbai0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1)Patients of ages above 18 years who have a current or previously diagnosed hematologic cancer within the past five years.
- •2)Diagnosed to have concomitant COVID-19 infection after 1stMarch 2020 through RT-PCR COVID-19 or antigen-based testing.
排除标准
- •1)Patients who are not on any treatment for hematologic cancer and are in remission formore than five years
- •2)Patients/family members unwilling to giving informed consent
- •3)Definitive diagnosis of hematologic cancer not made ante-mortem or post mortem
研究者
相似试验
招募中
不适用
SARS-CoV-2 (COVID-19) registry for oncological and hematological patients in GermanyCOVID-19, SARS-CoV-2 infectionMalignant tumorsHematological diseases (MDS, MPS, AA, ITP, PNH)DRKS00023012Arbeitsgemeinschaft der Hämatologen und Onkologen im Krankenhaus e.V. (ADHOK e.V., 1. Vorsitzender) St. Marienkrankenhaus Siegen170
尚未招募
不适用
Study of blood tests findings in patients of COVID 19 in a tertiary care centreCTRI/2020/07/026954GCS Medical College Hospital and Research Centre
尚未招募
不适用
ational Clinical Registry of COVID 19CTRI/2020/08/027164Indian Council of Medical Research
尚未招募
3 期
Perspective of cancer patient in COVID-19 pandemicCTRI/2020/10/028438nil
尚未招募
不适用
COVID-19 Seroprevalence Survey among Cancer Patients and Caregivers in Cancer CenterCOVIDᆧCancer patientsCancer caregiverSeroprevalanceTCTR20201214005Thailand Science Research and Innovation400